gvtcx

supplier · GB-PPONPWDD-6894-DXRM

Teva UK Limited

WF105HX combined from 4 published records

Teva UK Limited has won 185 UK public sector awards from 20 buyers since 2017. The typical award is worth £35,745,737.

as a supplier

185 recorded awards from 20 buyers , between 10 Aug 2017 and 26 Aug 2026.

awards won
185
exclusive
3%
5 sole-winner awards
median award
£35.7m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Teva UK Limited

How many public sector contracts has Teva UK Limited won?

Teva UK Limited has won 185 UK public sector contracts from 20 public bodies since 2017.

Which public bodies buy from Teva UK Limited?

Teva UK Limited has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and NHS England.

How large are Teva UK Limited's contracts?

The median published value of a contract won by Teva UK Limited is £35,745,737. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Teva UK Limited contracts are expiring soon?

6 contracts involving Teva UK Limited have end dates in the next 12 months, the earliest on 31 May 2027.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £15,529,352 26 Aug 2026
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 shared NHS England £813,863,584 31 May 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £4,213,176 30 Apr 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide shared NHS England £19,595,208 24 Mar 2026
Transitional Drugs 6 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £1,637,728 29 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £17,727,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin shared NHS England £25,881,000 25 Nov 2025
Transitional Drugs 5 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £5,577,339 25 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £17,843,324 10 Nov 2025
NHS National Framework for Generics Housekeeping shared NHS England £21,562,716 10 Nov 2025
NHS National Framework for Denosumab Injection commencing 1st January 2026 shared NHS England £37,694,000 29 Sept 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £688,834,174 30 Jul 2025
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 shared NHS England £782,917,972 30 Jul 2025
NHS National Framework for Transition products (Axitinib and Eltrombopag) shared NHS England £52,385,000 15 Jul 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products shared NHS England £11,656,086 15 Apr 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Framework for Transition products commencing 1 October 2024 shared NHS England £16,224,000 29 Sept 2024
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 shared NHS England £416,830,570 24 Jul 2024
NHS Branded Medicines Tranche Framework for London and South of England shared NHS England £380,950,720 21 Jul 2024

every contract won by Teva UK Limited →

as published

This page combines 4 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Teva UK Limited · WF10 5HX 151
TEVA UK LIMITED GB-PPON PWDD-6894-DXRM WF10 5HX 19
Teva UK Ltd GB-COH 00302461 WF10 5HX 15
Teva UK Ltd GB-COH 675217228 WF10 5HX 0

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 13 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 4 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.